PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues OHI Q1 2026 Earnings EPS Beats Estimates Amid Market Uncertainty ARW Q1 2026 Earnings Stellar EPS Surpasses Estimates by Over 80 ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline CNTA Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline